New Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansions

BLUEBELL, Pa.–(BUSINESS WIRE)–Slipstream co-authors a new CPT paper with practical guidance for using real-world data in FDA drug approvals and label expansions.